Half of pharma and biotech companies using AI and big data
A survey conducted by ICON has found sentiment towards artificial intelligence (AI) and digital tools in the clinical research sector …
Post
-
-
BioArctic doses first subject in Parkinson’s disease therapy trial
BioArctic has dosed the first subject with the monoclonal antibody, exidavnemab, in the randomised Phase IIa EXIdavnemab Synucleinopathy Trial (EXIST) …
-
Ryvu Therapeutics doses first subject in Phase II myelofibrosis treatment trial
Ryvu Therapeutics has initiated the Phase II trial, POTAMI-61, dosing the first subject with a small-molecule cyclin-dependent kinase (CDK) 8/19 …
-
Centenarians – unlocking the secrets of living to 100
The concept of extremely long life, popularised in films like Highlander, may seem like pure fiction, however; researchers are actively …
-
Nuvig secures $161m financing to support clinical studies for NVG-2089
Nuvig Therapeutics has closed a $161m Series B financing round to advance its preclinical pipeline and support NVG-2089’s clinical proof-of-concept …
-
“Systematic reviews” for underrepresented groups in trials needed, says WHO senior adviser
Systematic reviews are needed to address gaps in population representation in clinical trials to ensure the quality level of evidence …
-
Merus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers
Merus’ Bizengri (zenocutuzumab-zbco) has received accelerated approval from the US Food and Drug Administration (FDA), marking “an important milestone” in …
-
Merus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers
Merus’ Bizengri (zenocutuzumab-zbco) has received accelerated approval from the US Food and Drug Administration (FDA), marking “an important milestone” in …
-
Cidara achieves full enrolment in influenza prevention trial
Cidara Therapeutics has achieved full planned subject enrolment for the randomised Phase IIb NAVIGATE trial designed to assess the safety …
-
US reproductive laws could limit women’s participation in clinical trials
It has been over two years since the US Supreme Court’s decision in Dobbs versus Jackson Women’s Health to overturn …
-
Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area
Adaptive Research and Western Radiation Oncology (WRO) have partnered to expand access to cancer treatment studies for individuals in the …
-
Teva reports positive outcomes from episodic migraine trial in young patients
Teva Pharmaceutical Industries has reported positive outcomes from its multicentre Phase III SPACE trial of Ajovy (fremanezumab) as a preventive …
-
CEO of UnitedHealthcare, Brian Thompson, shot dead in New York City
The CEO of US healthcare insurance firm UnitedHealthcare Group has been shot dead by a masked gunman outside of the …
-
Lilly’s Zepbound wins the weight loss duel with Novo’s Wegovy
Eli Lilly has scored a win in the ongoing competition with Novo Nordisk in the obesity space, as a Phase …
-
Real world data and patient planning can keep trials from collapsing
The judicious use of real-world data (RWD) could keep a Phase I or II trial from collapsing with the market …
